Touyun Biotech Group Balance Sheet Health
Financial Health criteria checks 2/6
Touyun Biotech Group has a total shareholder equity of HK$203.9M and total debt of HK$452.7M, which brings its debt-to-equity ratio to 222%. Its total assets and total liabilities are HK$753.0M and HK$549.1M respectively.
Key information
222.0%
Debt to equity ratio
HK$452.72m
Debt
Interest coverage ratio | n/a |
Cash | HK$46.35m |
Equity | HK$203.89m |
Total liabilities | HK$549.13m |
Total assets | HK$753.02m |
Recent financial health updates
Touyun Biotech Group (HKG:1332) Is Carrying A Fair Bit Of Debt
Sep 19Here's Why Touyun Biotech Group (HKG:1332) Can Afford Some Debt
Sep 13Touyun Biotech Group (HKG:1332) Is Making Moderate Use Of Debt
May 18Here's Why Touyun Biotech Group (HKG:1332) Can Afford Some Debt
Dec 24Recent updates
What Touyun Biotech Group Limited's (HKG:1332) 46% Share Price Gain Is Not Telling You
Feb 07Some Touyun Biotech Group Limited (HKG:1332) Shareholders Look For Exit As Shares Take 42% Pounding
Dec 18Touyun Biotech Group (HKG:1332) Is Carrying A Fair Bit Of Debt
Sep 19Risks To Shareholder Returns Are Elevated At These Prices For Touyun Biotech Group Limited (HKG:1332)
Jul 28Here's Why Touyun Biotech Group (HKG:1332) Can Afford Some Debt
Sep 13Touyun Biotech Group (HKG:1332) Is Making Moderate Use Of Debt
May 18Here's Why Touyun Biotech Group (HKG:1332) Can Afford Some Debt
Dec 24Could The China Touyun Tech Group Limited (HKG:1332) Ownership Structure Tell Us Something Useful?
Mar 12If You Had Bought China Touyun Tech Group (HKG:1332) Shares A Year Ago You'd Have Earned 380% Returns
Jan 15The Executive Chairman of China Touyun Tech Group Limited (HKG:1332), Liang Wang, Just Bought 8.8% More Shares
Jan 15How Much Of China Touyun Tech Group Limited (HKG:1332) Do Insiders Own?
Dec 11Financial Position Analysis
Short Term Liabilities: 1332's short term assets (HK$181.5M) do not cover its short term liabilities (HK$336.4M).
Long Term Liabilities: 1332's short term assets (HK$181.5M) do not cover its long term liabilities (HK$212.7M).
Debt to Equity History and Analysis
Debt Level: 1332's net debt to equity ratio (199.3%) is considered high.
Reducing Debt: 1332's debt to equity ratio has increased from 34.2% to 222% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: Whilst unprofitable 1332 has sufficient cash runway for more than 3 years if it maintains its current positive free cash flow level.
Forecast Cash Runway: 1332 is unprofitable but has sufficient cash runway for more than 3 years, due to free cash flow being positive and growing by 8.7% per year.